NSUN5 and acute lymphoblastic leukemia: However, there was no association between the remaining polymorphisms, NSUN3 rs7653521 (OR = 1.067, 95% CI = 0.946–1.203, p = 0.291), NSUN5 rs1880948 (OR = 0.980, 95% CI = 0.862–1.114, p = 0.759), NSUN6 rs3740102 (OR = 0.959, 95% CI = 0.825–1.114, p = 0.581), and pediatric ALL risk (Table 1).